News & Analysis as of

United States Patent and Trademark Office › National Cancer Moonshot

The U.S. Patent and Trademark Office is an agency of the United States Department of Commerce that serves a fundamental role in the U.S. intellectual property system by issuing patents and registering trademarks.... more +
The U.S. Patent and Trademark Office is an agency of the United States Department of Commerce that serves a fundamental role in the U.S. intellectual property system by issuing patents and registering trademarks.    less -
Goodwin

USPTO Launches the Cancer Moonshot Expedited Examination Pilot Program

Goodwin on

On February 1, 2023, the United States Patent & Trademark Office (USPTO) will begin accepting petitions to accelerate examination under the Cancer Moonshot Expedited Examination Pilot Program (the “Moonshot Program”). The...more

Goodwin

USPTO Announces Cancer Moonshot Expedited Examination Program

Goodwin on

​​​​​​​The U.S. Patent and Trademark Office (“USPTO”) published a Notice in the Federal Register announcing a new pilot program entitled, “Cancer Moonshot Expedited Examination Pilot Program” (the “Cancer Moonshot Program”)...more

McDermott Will & Emery

PTO Announces Cancer Moonshot Expedited Examination Pilot Program

McDermott Will & Emery on

On December 8, 2022, the US Patent & Trademark Office (PTO) announced the launch of the Cancer Moonshot Expedited Examination Pilot Program (Cancer Moonshot Pilot). This program begins on February 1, 2023, and replaces the...more

Procopio, Cory, Hargreaves & Savitch LLP

New USPTO Pilot Program Offers Opportunities for Cancer/Oncology Companies

Procopio, Cory, Hargreaves & Savitch LLP on

In a key development for companies working to treat cancer, the U.S. Patent and Trademark Office (USPTO) has launched a potentially beneficial pilot program. This is the latest Biden Administration initiative stemming from...more

Ladas & Parry LLP

USPTO Announces Expedited Examination Pilot Program for Cancer Prevention Technologies

Ladas & Parry LLP on

In support of President Biden’s Cancer Moonshot program, the USPTO announced that it will expedite the examination of patent applications that pertain to technologies to prevent cancer and cancer mortality...more

Morgan Lewis

USPTO Introduces Cancer Moonshot Expedited Examination Pilot Program

Morgan Lewis on

The Cancer Moonshot Expedited Examination Pilot Program (the new Pilot) will accord special status (earlier examination) to patent applications directed to technologies to prevent cancer and cancer mortality. The new Pilot...more

Mintz - Intellectual Property Viewpoints

Extension of U.S. Patent and Trademark Office’s Cancer Immunotherapy Pilot Program

Mintz - Intellectual Property Viewpoints on

On June 19, 2017, the U.S. Patent and Trademark Office (USPTO) announced that it would be extending the Cancer Immunotherapy Pilot Program, which permits patent applications pertaining to cancer immunotherapy to be examined...more

Morrison & Foerster LLP

Cancer Moonshot: USPTO Extends Cancer Immunotherapy Pilot Program Initiative

Morrison & Foerster LLP on

The United States Patent and Trademark Office (PTO) issued a Notice today extending the Cancer Immunotherapy Pilot Program (Pilot Program), also known as “Patents 4 Patients.” The Pilot Program, which accelerates the...more

Foley & Lardner LLP

USPTO Extends Cancer Immunotherapy Pilot Program

Foley & Lardner LLP on

On June 29th, 2016, the USPTO announced the Cancer Immunotherapy Pilot Program to allow expedited examination of patent applications that pertain to cancer immunotherapy. Under the Program and after proper petition, the USPTO...more

Knobbe Martens

The USPTO “Patents 4 Patients” Program: What, How, and Why

Knobbe Martens on

On January 12, 2016, President Barack Obama announced his goal of a nationwide “Cancer Moonshot,” with the ultimate goal of accelerating cancer research “to end cancer as we know it” during his State of the Union Address As...more

Nutter McClennen & Fish LLP

USPTO Offers a Fast Track to Cancer Immunotherapy Patents

Nutter McClennen & Fish LLP on

The United States Patent Office (USPTO) is implementing a new program that provides prioritized examination of patent applications relating to cancer immunotherapy (Cancer Immunotherapy Pilot Program or Program). The new...more

Foley & Lardner LLP

USPTO Launches Patents 4 Patients

Foley & Lardner LLP on

To support the National Cancer Moonshot initiative, the USPTO has launched the Patents 4 Patients program, also known as the Cancer Immunotherapy Pilot Program. Under this program, applicants can obtain expedited examination...more

McDonnell Boehnen Hulbert & Berghoff LLP

USPTO Implements Pilot Program to Support President's National Cancer Moonshot

McDonnell Boehnen Hulbert & Berghoff LLP on

Last month, the U.S. Patent and Trademark Office published a notice in the Federal Register (81 Fed. Reg. 42328) regarding the implementation of a new pilot program that will provide for earlier review of patent applications...more

Miles & Stockbridge P.C.

Teaming Up to Cure Cancer "Patents 4 Patients" – Fast Track Review

Miles & Stockbridge P.C. on

The United States Patent and Trademark Office “USPTO” is launching the “Patents 4 Patients” initiative, which will provide an accelerated review for methods of cancer treatments. Effective on June 29, 2016 the new “Cancer...more

Sheppard Mullin Richter & Hampton LLP

PTO Cancer Immunotherapy Fast Track

Sheppard Mullin Richter & Hampton LLP on

In response to President Obama’s National Cancer Moonshot initiative to eliminate cancer, the USPTO has launched the “Cancer Immunotherapy Pilot Program.” The Pilot Program provides an accelerated review for applications...more

Mintz - Intellectual Property Viewpoints

USPTO Fast-Tracks Cancer Immunotherapy Patent Applications

Mintz - Intellectual Property Viewpoints on

Effective June 29, 2016, the United States Patent and Trademark Office (USPTO) implemented a pilot program to provide for earlier review of patent applications pertaining to cancer immunotherapy. The Cancer Immunotherapy...more

Ward and Smith, P.A.

New Patent Office Initiative Provides a Boost to Cancer Immunotherapy Patent Applications

Ward and Smith, P.A. on

On June 29, 2016, the United States Patent and Trademark Office (USPTO) announced that it is implementing a pilot program to more quickly review patent applications related to treating cancer using immunotherapy. This...more

17 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
Sign up Log in
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide